Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04805086
What this trial is testing

The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseCovid19
Guy's and St Thomas' NHS Foundation Trust 5
Not applicableStudy completedNCT03462524
What this trial is testing

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

Who this might be right for
Esophageal CancerRadiation PneumonitisPulmonary Fibrosis+8 more
St. James's Hospital, Ireland 384
Not applicableActive Not RecruitingNCT07571291
What this trial is testing

DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Who this might be right for
Pulmonary Fibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Testing effectiveness (Phase 2)Looking for participantsNCT06951217
What this trial is testing

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Who this might be right for
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc. 340
Not applicableStudy completedNCT02055222
What this trial is testing

Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease

Who this might be right for
Pulmonary FibrosisLung Disease
National Heart, Lung, and Blood Institute (NHLBI) 7
Not applicableStudy completedNCT01134822
What this trial is testing

Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Nottingham 330
Testing effectiveness (Phase 2)Ended earlyNCT06360094
What this trial is testing

Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 85
Early research (Phase 1)Study completedNCT05427253
What this trial is testing

First-in-human Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of C106 in Healthy Subjects

Who this might be right for
Safety IssuesToleranceIdiopathic Pulmonary Fibrosis+1 more
Vicore Pharma AB 80
Testing effectiveness (Phase 2)Looking for participantsNCT03803787
What this trial is testing

Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients

Who this might be right for
Radiation Pneumonitis
Instituto Nacional de Cancerologia de Mexico 72
Large-scale testing (Phase 3)Ended earlyNCT03733444
What this trial is testing

A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

Who this might be right for
Idiopathic Pulmonary Fibrosis
Lakefront Biotherapeutics NV 781
Not applicableStudy completedNCT05173571
What this trial is testing

Homecare Integral Support Program for IPF Patients

Who this might be right for
Idiopathic Pulmonary Fibrosis
Institut d'Investigació Biomèdica de Bellvitge 95
Not applicableLooking for participantsNCT07174102
What this trial is testing

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography

Who this might be right for
Reumatoid ArthritisInterstitial Lung Disease Due to Systemic Disease (Disorder)Idiopathic Pulmonary Fibrosis (IPF)+1 more
Azienda Unita Sanitaria Locale di Piacenza 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT06132256
What this trial is testing

MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Syndax Pharmaceuticals 145
Testing effectiveness (Phase 2)UnknownNCT04482595
What this trial is testing

BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients

Who this might be right for
COVID-19Long COVIDPulmonary Fibrosis+1 more
Humanetics Corporation 50
Testing effectiveness (Phase 2)Looking for participantsNCT07464132
What this trial is testing

Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

Who this might be right for
TumorCardiovascular DiseasesPulmonary Fibrosis+3 more
Peking Union Medical College Hospital 30
Post-approval studies (Phase 4)Study completedNCT02143687
What this trial is testing

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

Who this might be right for
Precapillary Pulmonary HypertensionInterstitial Lung Disease
University of Zurich 30
Not applicableStudy completedNCT05366387
What this trial is testing

Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Tours 9
Not applicableNot Yet RecruitingNCT07178392
What this trial is testing

Disease-syndrome Characteristics of IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Henan University of Traditional Chinese Medicine 2,864
Not applicableNot Yet RecruitingNCT07222592
What this trial is testing

MOBoxy: MoblO2 to Maintain Oxygenation

Who this might be right for
COPDInterstitial Lung Disease
National Jewish Health 48
Testing effectiveness (Phase 2)Looking for participantsNCT05120934
What this trial is testing

Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough

Who this might be right for
Interstitial Lung Disease
Mayo Clinic 25
Next Page